A phase IB trial of paclitaxel and carboplatin + galunisertib in patients with uterine and ovarian carcinosarcoma

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.06.048 ◽

2020 ◽

Vol 159 ◽

pp. 23

Author(s):

C.C. Gunderson ◽

J.L. Walker ◽

R.S. Mannel ◽

L.L. Holman ◽

D.L. Richardson ◽

...

Keyword(s):

Phase Ib ◽

Ovarian Carcinosarcoma

Download Full-text

OVARIAN CARCINOSARCOMA WITH PERIRENAL METASTASIS: A CASE REPORT

10.26226/morressier.597eedbed462b80296ca184f ◽

2017 ◽

Author(s):

Ngu Siew Fei

Keyword(s):

Case Report ◽

Ovarian Carcinosarcoma

Download Full-text

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Case Medical Research ◽

10.31525/ct1-nct03913234 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Download Full-text

A Phase Ib Study of HMPL-523 in Immune Thrombocytopenia Patients

Case Medical Research ◽

10.31525/ct1-nct03951623 ◽

2019 ◽

Author(s):

Keyword(s):

Immune Thrombocytopenia ◽

Download Full-text

TRIO Bladder: A Phase Ib Study of Durvalumab (MEDI 4736) Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation, Based on Molecular Subtypes in Muscle-Invasive Bladder Cancer

Case Medical Research ◽

10.31525/ct1-nct04073160 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Molecular Subtypes ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Phase Ib ◽

Muscle Invasive

Download Full-text

R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty

Case Medical Research ◽

10.31525/ct1-nct04120350 ◽

2019 ◽

Author(s):

Keyword(s):

Newly Diagnosed ◽

Phase Ib ◽

Multicenter Phase

Download Full-text

A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BCO2)

Case Medical Research ◽

10.31525/ct1-nct04239313 ◽

2020 ◽

Author(s):

Keyword(s):

Mycobacterium Tuberculosis ◽

Phase Ib ◽

Download Full-text

Faculty of 1000 evaluation for A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718056364.793482065 ◽

2013 ◽

Author(s):

Mark Faries

Keyword(s):

Dendritic Cell ◽

Advanced Melanoma ◽

Phase Ib ◽

Cell Immunotherapy ◽

Melanoma Patients ◽

Download Full-text

Faculty Opinions recommendation of Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734654973.793555799 ◽

2019 ◽

Author(s):

Graham Pawelec

Keyword(s):

T Cell ◽

T Cell Responses ◽

Phase Ib ◽

Download Full-text

Faculty Opinions recommendation of Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2- Advanced Breast Cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738775672.793581181 ◽

2020 ◽

Author(s):

Jason S Carroll

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Dose Escalation ◽

Advanced Breast ◽

Download Full-text

A phase Ib study of preoperative, locoregional IRX-2 cytokine immunotherapy to prime immune responses in patients with early stage breast cancer

immuneACCESS ◽

10.21417/dbp2019ccr ◽

2020 ◽

Author(s):

DB Page ◽

J Pucilowska ◽

KG Sanchez ◽

VK Conrad ◽

AK Conlin ◽

...

Keyword(s):

Breast Cancer ◽

Immune Responses ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Download Full-text